Cargando…

Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711502/ https://www.ncbi.nlm.nih.gov/pubmed/31454358 http://dx.doi.org/10.1371/journal.pone.0220759

Ejemplares similares

Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
por: Yu, Xiaobo, et al.
Publicado: (2011)

Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
Publicado: (2019)

Retracted: Clinical Efficacy of Topical Tacrolimus on Conjunctival Hyperemia Caused by Prostaglandin Analogues
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Meta-Analysis for Social Support Degree of Kidney Transplant Recipients: Evidence from China
por: Healthcare Engineering, Journal of
Publicado: (2023)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
por: Dashti-Khavidaki, S., et al.
Publicado: (2016)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

Retraction: Pretransplant Prediction of Posttransplant Survival for Liver Recipients with Benign End-Stage Liver Diseases: A Nonlinear Model
Publicado: (2019)

Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India
por: Prasad, Narayan, et al.
Publicado: (2019)

Retracted: A Correlation Analysis between SNPs and ROIs of Alzheimer's Disease Based on Deep Learning
por: International, BioMed Research
Publicado: (2023)

Retracted: Successful Treatment of Refractory Wart with a Topical Activated Vitamin D in a Renal Transplant Recipient
por: in Transplantation, Case Reports
Publicado: (2022)

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
por: Tang, Jiang-Tao, et al.
Publicado: (2018)

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021)

Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2019)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure
Publicado: (2019)

The real experience of patients after liver transplantation in intensive care unit: Retraction
Publicado: (2021)

Retracted: Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells
por: International, BioMed Research
Publicado: (2016)

Retraction Note: 11,670 whole-genome sequences representative of the Han Chinese population from the CONVERGE project
por: Cai, Na, et al.
Publicado: (2020)

Genotype-guided tacrolimus dosing in African American kidney transplant recipients
por: Sanghavi, K., et al.
Publicado: (2015)

Lower versus higher starting tacrolimus dosing in kidney transplant recipients
por: Chua, Justin C. M., et al.
Publicado: (2022)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Publicado: (2019)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Retraction: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China
Publicado: (2019)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation
Publicado: (2019)

Retracted: Change in Health-Related Quality of Life in Cochlear Implant Recipients in China
por: Healthcare Engineering, Journal of
Publicado: (2023)

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019)

Variations in different polycystic ovary syndrome phenotypes in a population of Chinese Han
por: Huang, Rong, et al.
Publicado: (2014)

Retraction: rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population
Publicado: (2018)

Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
Publicado: (2019)

Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation
por: Chen, Yi-kuan, et al.
Publicado: (2014)

Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients
por: Zhu, Huaijun, et al.
Publicado: (2022)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Hepatic sinusoidal obstruction syndrome due to tacrolimus in a liver-transplantation recipient
por: Zhou, Shuang-Nan, et al.
Publicado: (2020)

Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19
por: Pearson, Meredith M., et al.
Publicado: (2021)

Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation
Publicado: (2019)

Retraction: The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vqr113qq3q10scblqrjtt1kavt